Insulet (PODD) Retained Earnings (2010 - 2026)
Insulet's (PODD) quarterly Retained Earnings came in at $1.3 billion in Q2 2026, down 5.1% on a YoY basis from $1.4 billion in Q2 2025, and up 2.2% quarter-over-quarter from $1.3 billion in Q1 2026.
Analysis
Insulet (PODD) Retained Earnings (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Retained Earnings for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings fell 5.1% year-over-year to $1.3 billion; the trailing twelve-month figure through Jun 2026 stood at $1.3 billion (down 5.1% YoY), and the FY2025 full-year result was $1.3 billion, up 7.64% from the prior year.
- Retained Earnings climbed to $1.3 billion in Q2 2026 per PODD's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.4 billion in Q2 2025 and bottomed at $995.5 million in Q1 2022.
- Historically, Retained Earnings has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings dropped 20.25% in 2022, then rose 20.94% in 2025.
- Over 5 years, Retained Earnings stood at $1.0 billion in 2022, then increased by 5.96% to $1.1 billion in 2023, then increased by 7.42% to $1.2 billion in 2024, then climbed by 7.64% to $1.3 billion in 2025, then advanced by 2.67% to $1.3 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $1.3 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 1.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.27 Bn |
| Sep 30, 2025 | 1.25 Bn |
| Jun 30, 2025 | 1.38 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 1.12 Bn |
| Dec 31, 2023 | 1.10 Bn |
| Sep 30, 2023 | 1.08 Bn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.05 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 1.01 Bn |
| Mar 31, 2022 | 995.50 Mn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.18 Bn |